Milwaukee pharmaceutical company Estrigenix Therapeutics gets SBIR grant
Estrigenix Therapeutics, Inc. is the recipient of a $300,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR) grant.
Stay updated with breaking news from Daniel Sem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Estrigenix Therapeutics, Inc. is the recipient of a $300,000 National Institute of Health (NIH) Small Business Innovation Research (SBIR) grant.
MEQUON — Concordia University Wisconsin Dean of the Business School Daniel Sem has announced that he is leaving the position to become vice provost for Research and Innovation.
ONLINE: Wisconsin Innovation Network press release: From lab to marketplace: Learn how Milwaukee tech transfer works at Jan. 26 Tech Council webinar A growing commercial pathway for intellectual property in Wisconsin runs through research and development engines in the Milwaukee region, both private and public. Join âtechnology transferâ leaders from five of those entities for a webinar 10 a.m. Tuesday, Jan. 26. The webinar is hosted by the Wisconsin Technology Council and is the latest in the Tech Council Innovation Networkâs c...